ABPI Public Disclosure of Payments from Pharmaceutical Companies to HCPs
Poll of 508 healthcare professionals on the public disclosure of payments to healthcare professionals from pharmaceutical companies.

87% of HCPs believe payments from pharmaceutical companies to individually named healthcare professionals should be transparent, with around two thirds (64%) saying that this information should be publicly declared.

Two thirds (66%*) of HCPs with a current relationship with one or more pharmaceutical companies for which they receive payment or benefit in kind say that they have already given or are likely to give permission to the pharmaceutical companies they work with to disclose their payment information on the ABPI database when it launches on 30 June.

CONTACT US TO FIND OUT MORE ABOUT HOW WE CAN HELP YOU
Date Published
17th May 2016
Categories
Client
ABPI
Methodology
ComRes interviewed 508 healthcare professionals online between 15th March  and 4th April 2016. The sample of respondents included an equal split of GPs, Hospital Specialists, Pharmacists and Nurses from throughout the UK.

SHARE THIS STORY